Home › Drugs › Gliclazide / Glibenclamide
Gliclazide / Glibenclamide
غليكلازيد / غليبنكلاميد · Sulfonylurea (oral antidiabetic) · Endocrine & diabetes
Acts on: Pancreas
Main adverse effects on: Cerebrum
Mechanism of action
Stimulates pancreatic beta cells to release insulin regardless of the glucose level.
Uses
Type 2 diabetes (often with metformin).
Side effects
- Hypoglycaemia — can be prolonged, especially glibenclamide in older adults and renal impairment
- Weight gain
🚫 Contraindications
- Type 1 diabetes and ketoacidosis
- Severe renal or hepatic impairment
- Pregnancy and breastfeeding (switch to insulin)
- Porphyria
🤰 Pregnancy
Contraindicated Switch to insulin (neonatal hypoglycaemia).
🍼 Breastfeeding
Avoid Avoid (infant hypoglycaemia).
Clinical points & patient counselling
Give with breakfast. Teach not to skip meals and to recognise hypoglycaemia. Hypoglycaemia from these drugs needs monitoring for hours after treatment.
Tests to monitor
⚕️ Educational content; it does not replace a doctor, pharmacist or official references. Values and doses vary by lab, country and leaflet.